It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment......
(read more)January 9 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook......
(read more)December 6 - Hedge Funds, News - Comments
How Jim Simons Built the World’s Most Lucrative Black Box (Bloomberg) Anyone looking to learn how a quant fund conquered the financial world should......
(read more)November 1 - Hedge Funds, Insider Trading - Comments
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (......
(read more)October 12 - Hedge Funds, News - Comments
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......
(read more)June 19 - Hedge Funds, News - Comments
“October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers......
(read more)April 18 - Hedge Funds, News - Comments
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity......
(read more)December 21 - Hedge Funds, News - Comments
‘There’s Finally an Alternative to Equities,’ Says Billionaire Fund Manager (MarketWatch) The stock market’s main gauges will rack up weekly gains......
(read more)May 11 - Hedge Funds, Insider Trading - Comments
Einhorn Says Greenlight Underperformance Is Worst Since 2000 (Bloomberg) Hedge fund manager David Einhorn said a shift in favor of value stocks may soon......
(read more)February 21 - Hedge Funds, Insider Trading - Comments
Seattle Genetics Inc (NASDAQ:SGEN): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......
(read more)February 7 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......
(read more)May 18 - Hedge Funds - Comments
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research......
(read more)December 1 - Hedge Funds, News - Comments
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......
(read more)November 14 - Hedge Funds, News - Comments
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay......
(read more)September 22 - Hedge Fund Analysis, Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors reported raising its stake in Seattle Genetics Inc (NASDAQ:SGEN) to 44.35 million common shares,......
(read more)September 16 - Hedge Funds, News - Comments
Seattle Genetics, Inc. (NASDAQ:SGEN) just reported second quarter financials, and the company is up nearly 10% on the data. Alongside the numbers, however......
(read more)July 28 - News, Stock Analysis - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......
(read more)May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things......
(read more)March 8 - Hedge Funds, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......
(read more)February 25 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the......
(read more)February 24 - Hedge Funds, News - Comments
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should......
(read more)February 24 - Hedge Funds, News - Comments
Given elite hedge funds have filed their latest 13F’s, we have an opportunity to analyze what hedge funds like and what they don’t like. Since......
(read more)December 11 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......
(read more)December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply......
(read more)November 24 - Hedge Funds, News - Comments
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......
(read more)November 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
Generally, insider trading activity represents an important tool in the process of fundamental security analysis, as it can offer some insights on how......
(read more)November 9 - Insider Trading, News - Comments
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In......
(read more)September 16 - Hedge Funds, News - Comments
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting......
(read more)July 10 - Hedge Funds, News - Comments
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc......
(read more)March 5 - Hedge Funds, News - Comments
Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued......
(read more)December 15 - Hedge Funds, News - Comments
In several new filings with the Securities and Exchange Commission, Julian and Felix Bakers‘ healthcare-focused fund Baker Bros. Advisors reported......
(read more)November 12 - Hedge Funds, News - Comments
Over the past week, a few multi millionaire insider purchases caught my eye. In this article, I will look into three particular companies that saw their......
(read more)June 10 - Hedge Funds, Insider Trading - Comments
Baker Bros. Advisors, managed by Julian Baker and Felix Baker, have disclosed raising its stake in Seattle Genetics Inc. (NASDAQ:SGEN). In a new filing......
(read more)May 19 - Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares......
(read more)January 2 - Hedge Funds, News - Comments
Julian Baker and Felix Baker have increased their exposure to Seattle Genetics, Inc. (NASDAQ:SGEN) even higher. In a newly amended filing with the SEC......
(read more)December 17 - Hedge Funds, News - Comments
Julian Baker and Felix Baker are betting big on Seattle Genetics, Inc. (NASDAQ:SGEN). In a recent Form 4 filing with the Securities and Exchange Commission......
(read more)December 6 - Hedge Funds, News - Comments
Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary......
(read more)November 29 - Hedge Funds - Comments
In pharmacology, we don’t only have to consider the actions of the drug on the body. It is also important to understand the way the body processes......
(read more)September 12 - News - Comments
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......
(read more)September 10 - News - Comments
In late August, Amgen agreed to buy Onyx Pharmaceuticals in one of the worst-kept M&A secrets of the year. Amgen paid 50% more than Onyx’s pre......
(read more)September 9 - News - Comments
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for......
(read more)September 9 - News - Comments
As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares......
(read more)September 9 - News - Comments
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge......
(read more)August 27 - News - Comments
As I’m sure you’ve probably heard by now, Amgen, Inc. (NASDAQ:AMGN) agreed to purchase Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) for $125......
(read more)August 26 - News - Comments
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......
(read more)August 26 - News - Comments
Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze......
(read more)August 26 - News - Comments
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......
(read more)August 25 - News - Comments
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more......
(read more)August 23 - News - Comments
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (......
(read more)August 23 - News - Comments
Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star......
(read more)August 6 - News - Comments
